Phase I clinical trial of autologous T-cells genetically engineered with a chimeric receptor to target the follicle-stimulating hormone receptor (FSHR) in recurrent ovarian cancers (OVCAs)

Gynecologic Oncology 2026

View at publisher
Authors: Robert Wenham, Marco Davila, Daniel Abate-Daga, Melissa J. McGettigan, Xuefeng Wang, Theresa A. Boyle, Pamela Garzone, Amit kumar, Richard Chikara Koya, Jose Conejo-garcia
DOI: 10.1016/j.ygyno.2026.01.314
Cited by: 1

Fields of Study & Subjects

CAR-T cell therapy research Pluripotent Stem Cells Research Reproductive System and Pregnancy

Publication details

Journal / source
Gynecologic Oncology
Publisher
Elsevier BV
Volume
208
Pages
S162–S162
Publication date
23 April 2026
Language
EN